Domov › Rak prostate › Kalifornija

Klinične študije za Rak prostate v Kalifornija

156 študij za Rak prostate išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
in še 18

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT07200830

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
in še 10

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
in še 20

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Enloe Medical Center, Chico
UC San Diego Health System - Encinitas, Encinitas
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
in še 4

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

City of Hope, Duarte
Cedars-Sinai Medical Center, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 30. sep. 2026 · NCT05534646

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

University of California San Diego Health, San Diego

Vključevanje udeležencevFaza 4

Starost 18 in več · Moški · Posodobljeno 29. sep. 2026 · NCT07569926

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18–90 · Moški · Posodobljeno 29. sep. 2026 · NCT07185165

Precision-Based Genomics in Prostate Cancer

University of California San Diego, La Jolla
University of California San Francisco, San Francisco

Vključevanje udeležencevOpazovalna študija

Starost 18–120 · Moški · Posodobljeno 28. sep. 2026 · NCT04706663

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Om Research, San Diego

Vključevanje udeležencevOpazovalna študija

Starost 40–75 · Moški · Posodobljeno 28. sep. 2026 · NCT07543757

DESTINY-PANTUMOUR04

Research Site, San Diego

Vključevanje udeležencevOpazovalna študija

Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 18–130 · Moški · Posodobljeno 25. sep. 2026 · NCT07181161

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

University of California San Diego, Moores Cancer Center, La Jolla

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 25. sep. 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location), Beverly Hills
in še 20

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 24. sep. 2026 · NCT07028853

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

START Los Angeles, Los Angeles

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 24. sep. 2026 · NCT07719361

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

VA Greater LA Healthcare System, Los Angeles
VA Palo Alto Health Care System, Palo Alto
Stanford University Medical Center, Palo Alto
in še 2

Vključevanje udeležencevFaza 2/3

Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06780670

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

City of Hope National Medical Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Duarte
Providence Saint Jude Medical Center, Fullerton
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 22. sep. 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Univ Cali Irvine ALS Neuromuscular, Orange
Stanford University Medical Center, Palo Alto
Sansum Clinic, Santa Barbara

Vključevanje udeležencevFaza 3

Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, La Jolla
Research Site, La Jolla
Research Site, Los Angeles
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 18. sep. 2026 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

City of Hope Comprehensive Cancer Center ( Site 0049), Duarte
City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
Moores Cancer Center ( Site 0010), La Jolla
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

GSK Investigational Site, La Jolla

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Moški · Posodobljeno 16. sep. 2026 · NCT07332455

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Hoag Memorial Hospital Presbyterian, Irvine

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 15. sep. 2026 · NCT07581184

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

USNC, Mountain View
Tri Valley Urology, Murrieta
University of California San Francisco, San Francisco

Vključevanje udeležencev

Starost 18 in več · Moški · Posodobljeno 14. sep. 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Urology Group of Southern California, Los Angeles
Greater Los Angeles VA Medical Center, Los Angeles
UC Irvine Health, Orange
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Kaiser Permanente-Deer Valley Medical Center, Antioch
Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
in še 34

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

UCI Health Chao Family Comprehensive Cancer Center, Orange
Investigational Site Number: 403, Palo Alto

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05997615

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

University of California, San Francisco, San Francisco

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05766371

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

Duarte Cancer Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

Vključevanje udeležencev

Starost 18 in več · Moški · Posodobljeno 9. sep. 2026 · NCT05804318

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06440005

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Moški · Posodobljeno 8. sep. 2026 · NCT06067295

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

UC San Diego Moores Cancer Center, La Jolla

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 3. sep. 2026 · NCT07545811

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Sharp HealthCare - Sharp Memorial Hospital, San Diego

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 3. sep. 2026 · NCT07005154

Prostate Active Surveillance Study

Veterans Affairs San Francisco Health Care System, San Francisco
University of California, San Francisco, San Francisco
Stanford University, Stanford

Vključevanje udeležencevOpazovalna študija

Starost 21 in več · Moški · Posodobljeno 2. sep. 2026 · NCT00756665

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.